NCT07465393 Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors
| NCT ID | NCT07465393 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Valeria Chiu |
| Condition | Breast Neoplasms |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2026-01-05 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2026-01-05 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the comparative effectiveness of a multi-modal facility-based rehabilitation program (therapist-led resistance exercise and relaxation training) versus a self-directed home-based resistance exercise program in post-treatment breast cancer survivors. Participants in both intervention groups will complete a 16-week program consisting of two exercise sessions per week.The multimodal, therapist-led approach is hypothesized to result in superior improvements in physical performance and quality of life outcomes compared to self-directed home exercise
Eligibility Criteria
Inclusion Criteria: * Histologically confirmed primary breast cancer * Stage I-III non-metastatic breast cancer following lumpectomy or mastectomy * Completed adjuvant chemotherapy (with or without radiotherapy) * Age ≥ 18 years * Able to understand and follow the study protocol * Willingness to attend facility-based exercise training. Exclusion Criteria: * Metastatic (Stage IV) breast cancer * Morbid obesity (BMI \> 40 kg/m²) * Uncontrolled hypertension (systolic blood pressure \> 180 mmHg and/or diastolic blood pressure \> 99 mmHg) * Presence of implantable medical devices (e.g., pacemakers, nerve stimulators) * Presence of metallic surgical implants (e.g., total hip or knee replacements) that interfere with assessment devices * Contraindications for resistance training (e.g., acute infectious disease, severe cardiac disease, severe respiratory insufficiency) * Concurrent malignant diseases * Current participation in intense systematic exercise training (defined as at least 1 hour, twice per week) * Previous participation in an exercise intervention clinical trial.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07465393 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07465393 currently recruiting?
Yes, NCT07465393 is actively recruiting participants. Contact the research team at haydenbell28@gmail.com for enrollment information.
Where is the NCT07465393 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT07465393 clinical trial?
NCT07465393 is sponsored by Valeria Chiu. The trial plans to enroll 66 participants.